RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050609 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Katherine A Rauen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Genomic Medicine, University of California Davis, Sacramento, CA, 95817, USA. Hauptthemen laut MEDLINE: Muscle, Skeletal, ras Proteins, Muscle Development. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIAMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
RASopathies are rare developmental genetic syndromes caused by germline pathogenic variants in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) signal transduction pathway. Although the incidence of each RASopathy syndrome is rare, collectively, they represent one of the largest groups of multiple congenital anomaly syndromes and have severe developmental consequences. Here, we review our understanding of how RAS/MAPK dysregulation in RASopathies impacts skeletal muscle development and the importance of RAS/MAPK pathway regulation for embryonic myogenesis. We also discuss the complex interactions of this pathway with other intracellular signaling pathways in the regulation of skeletal muscle development and growth, and the opportunities that RASopathy animal models provide for exploring the use of pathway inhibitors, typically used for cancer treatment, to correct the unique skeletal myopathy caused by the dysregulation of this pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Genomic Medicine, University of California Davis, Sacramento, CA, 95817, USA.
- University of California Davis MIND Institute, Sacramento, CA 95817, USA.
ORCID-Profile: Katherine A Rauen
Förderung
- NICHD NIH HHS
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Rauen, K. A., & Tidyman, W. E. (2024). RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050609
Vancouver
Rauen KA, Tidyman WE. RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050609
BibTeX
@article{Rauen2024,
author = {Rauen, Katherine A and Tidyman, William E},
title = {RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050609}
}
EUVIMED